News: Boehringer Ingelheim announces appointment of Vani Manja as India Country MD

C-Suite

Boehringer Ingelheim announces appointment of Vani Manja as India Country MD

Vani succeeds Sharad Tyagi, who retired from Boehringer Ingelheim India on December 31, 2020 after over a decade of successful and dedicated service to the company.
Boehringer Ingelheim announces appointment of Vani Manja as India Country MD

Boehringer Ingelheim has announced that Vani Manja is appointed Country Managing Director for India, effective January 1, 2021. In this role, she will assume responsibility for the Company’s businesses in India, Bangladesh, Nepal and Sri Lanka. Vani will also join the Board of the Company.

Vani succeeds Sharad Tyagi, who retired from Boehringer Ingelheim India on December 31, 2020 after over a decade of successful and dedicated service to the company. During his tenure, Sharad built Boehringer Ingelheim India to be one of India’s fastest growing multinational pharmaceutical companies.

Announcing Vani’s appointment, Thorsten Poehl, Head of Emerging Markets, Boehringer Ingelheim said, “India presents a unique opportunity for Boehringer Ingelheim, wherein we affirm our commitment to patients and people in the country with our products and services. Vani is a proven and respected leader who lives our Company values and has a strong track record of leading complex transformations and delivering results. With her unwavering commitment to patients, customers and employees, I am confident that Vani will lead the India business to build patient-friendly access and benefit models in the years to come.

At this juncture, I would like to thank Sharad for his leadership in building a strong foundation to Boehringer Ingelheim India’s business. He has been instrumental in executing a successful high-growth strategy. I wish Sharad a great life after retirement, and Vani a successful and fulfilling career in Boehringer Ingelheim India.”

Vani was formerly the Global Head of Boehringer Ingelheim’s Go-To-Market and Business Steering organization, based in the Company’s headquarters in Germany. She joined Boehringer Ingelheim in the US in 2011, working across Strategy & Operations, Marketing and Sales leadership roles before moving to Ingelheim in 2016 as Regional Business Manager for Japan. Her global experience in Healthcare spans nearly two decades across McKinsey & Company, Becton Dickinson and Boehringer Ingelheim, and is characterized by strong global mobility and cross-functional leadership assignments across Healthcare and Management Consulting. Prior to embarking on her international career, she served as a commissioned officer in the Indian Army Ordnance Corps.

Vani holds an MBA and MA in International Studies from the Wharton School at the University of Pennsylvania in Philadelphia, and a Bachelor’s degree with Honors in Chemistry from Delhi University.

Vani Manja, Country Managing Director, Boehringer Ingelheim India said, “I am excited and honored to return to India to lead a successful organization with a highly talented team. I look forward to working with our customers, partners and leaders in healthcare to improve the lives of patients through innovative therapies, after all the years of remotely following the huge strides India has taken towards developing healthcare.”

Read full story

Topics: C-Suite, #Appointments

Did you find this story helpful?

Author

QUICK POLL

What is your top focus area for reinventing work in the hybrid world of work?

2 months free subscription
q_auto,f_auto/v1617612749/mag-april-2021.png

Subscribe to all new People Matters HR Magazine

.

Subscribe
And Save 59% plus Two months free

Subscribe now

What are your key focus areas as you continue to reinvent your business amid the ongoing uncertainty? READ the April 2021 issue of our magazine to find out the reinvention story of global leaders.

Read Now